FIELD: pharmacology; medicine.
SUBSTANCE: group of inventions relates to the field of pharmacology and medicine; it is intended for the effect on inflammation mechanisms in mammals. In particular, the use of a compound of the formula (Ib) is described, as well as a pharmaceutical composition based on this compound as an anti-inflammatory agent that affects inflammation mechanisms in animals. In addition, the group of inventions relates to a method (in vivo) for the suppression or inhibition of response inflammatory reactions by using the compound (Ib) and to a method for the suppression or inhibition of expression of at least one cytokine by injecting the compound (Ib). The present invention relates to compounds of functionalized saccharides used as anti-inflammatory agents that affect inflammation mechanisms in mammals.
EFFECT: providing an effective impact on inflammation mechanisms in mammals.
Formula (Ib)
11 cl, 8 tbl, 6 ex
| Title | Year | Author | Number |
|---|---|---|---|
| TRIPEPTIDES | 2014 |
|
RU2669939C2 |
| BORON-BASED SMALL MOLECULES AS ANTI-INFLAMMATORY DRUGS | 2007 |
|
RU2508113C2 |
| NICOTINE RECEPTOR AGONISTS AND METHODS OF USING THEREOF FOR TREATING INFLAMMATORY DISEASES | 2005 |
|
RU2414461C2 |
| BORON-CONTAINING SMALL MOLECULES AS ANTI-INFLAMMATORY AGENTS | 2007 |
|
RU2642628C2 |
| METHODS FOR TREATING INFLAMMATION, AUTOIMMUNE DISORDERS AND PAIN | 2014 |
|
RU2669800C2 |
| OXIDISED LIPIDES AND USE THEREOF FOR TREATING INFLAMMATORY DISEASES AND DISORDERS | 2009 |
|
RU2482854C2 |
| OCTAHYDROPENTALENE COMPOUNDS AS CHEMOKINE RECEPTOR ANTAGONISTS | 2008 |
|
RU2481332C2 |
| APPLICATION OF STABILISERS OF HIF- ALPHA FOR INTENSIFICATION OF ERYTHROPOIESIS | 2004 |
|
RU2414214C2 |
| IMMUNOMODULATORY COMPOUNDS AND TREATING DISEASES CONNECTED WITH INFLAMMATORY CYTOKINES | 2007 |
|
RU2498813C2 |
| DEAZAPURINES AND USE THEREOF | 2003 |
|
RU2380368C2 |
